Our Pipeline

Building a pipeline to bring the promise of cell therapies to more patients

Pre-clinical
Phase 1
Phase 2/3¹
Pre-clinical
Phase 1
Phase 2/3¹

Glioblastoma

Melanoma

Colorectal

Prostate

Neuroendocrine

Colorectal

Pancreatic

Gastric

¹ Phase 3 may not be required if Phase 2 is registrational

Clinical Trials

CHM 1101 (CLTX CAR T) Phase 1 Clinical Trial

Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T Cells Incorporating a Chlorotoxin Tumor-targeting Domain for Patients with MMP2+ Recurrent or Progressive Glioblastoma

CHM 1101 Phase 1 Clinical Trial

CHM 1101 Phase 1 Clinical Trial​
click to enlarge

Dosing Schema

Dosing Schema​
click to enlarge

Design

click to enlarge

Publications